首页> 美国卫生研究院文献>British Journal of Cancer >Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.
【2h】

Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.

机译:使用谷胱甘肽-S-转移酶-MUC1细菌融合蛋白生产抗乳腺癌单克隆抗体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two murine Mabs VA1(IgG1) and VA2(IgG1) were produced against a bacterial fusion protein comprising glutathione S-transferase and five tandem repeats of the MUC1 protein. Using the immunoperoxidase staining technique, VA1 detected 46/53 and VA2 detected 48/53 breast cancers and both also reacted with a range of other human epithelial carcinomas. In addition VA1 gave weak reactions with normal breast tissues whereas VA2 was non-reactive and could be a relatively tumour specific antibody for breast cancer. The antibodies were also tested by ELISA-VA1 reacted weakly with glycosylated HMFG but strongly with deglycosylated HMFG, whereas VA2 reacted strongly with both forms of HMFG. The reactivities of the two Mabs with synthetic peptides of the MUC1 tandem repeat were used to map the epitopes recognised by VA1 (amino acids RPAPGS) and VA2 (amino acids DTRPA). The use of fusion proteins provides another means of immunisation to produce anti-tumour antibodies.
机译:针对包含谷胱甘肽S-转移酶和MUC1蛋白的五个串联重复序列的细菌融合蛋白,产生了两个鼠单克隆抗体VA1(IgG1)和VA2(IgG1)。使用免疫过氧化物酶染色技术,VA1检测到46/53,VA2检测到48/53乳腺癌,并且都与一系列其他人类上皮癌发生了反应。此外,VA1与正常乳腺组织的反应较弱,而VA2无反应性,可能是乳腺癌相对肿瘤特异性的抗体。抗体还通过ELISA进行了测试-VA1与糖基化HMFG弱反应,但与去糖基化HMFG强烈反应,而VA2与两种形式的HMFG强烈反应。两个Mab与MUC1串联重复序列的合成肽的反应性用于定位VA1(氨基酸RPAPGS)和VA2(氨基酸DTRPA)识别的表位。融合蛋白的使用提供了另一种产生抗肿瘤抗体的免疫方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号